Brief: Seastar Medical Stanford Medicine Is Cleared To Actively Enroll Subjects In Adult Acute Kidney Injury Pivotal Trial
23/10/2024 13:44
Oct 23 (Reuters) - SeaStar Medical Holding Corp ICU.O :
* SEASTAR MEDICAL: STANFORD MEDICINE IS CLEARED TO ACTIVELY
ENROLL
SUBJECTS IN ADULT ACUTE KIDNEY INJURY PIVOTAL TRIAL
Source text for Eikon: ID:nGNX8FlqK3
Further company coverage: ICU.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview